HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$23.03
Day range
$22.01 - $23.76
Year range
$6.13 - $44.54
Market cap
1.34B USD
Avg Volume
669.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 183.66M | 21.94% |
Net income | -240.44M | -357.08% |
Net profit margin | — | — |
Earnings per share | -1.39 | — |
EBITDA | -71.30M | -28.26% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 343.19M | -2.16% |
Total assets | 383.64M | 3.70% |
Total liabilities | 141.50M | 146.04% |
Total equity | 242.14M | — |
Shares outstanding | 57.36M | — |
Price to book | 5.19 | — |
Return on assets | -50.53% | — |
Return on capital | -80.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -240.44M | -357.08% |
Cash from operations | -52.41M | -35.95% |
Cash from investing | -93.36M | -2,399.71% |
Cash from financing | 140.84M | 7,500.81% |
Net change in cash | -4.92M | 87.78% |
Free cash flow | -64.05M | -338.86% |
About
Founded
2019
Headquarters
Website
Employees
167
